Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding? Academic Article uri icon

abstract

  • Key Points Targeting of an anticlotting drug to activated platelets promises effective blood clot prevention without bleeding side effects.

publication date

  • 2013

published in